Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells.

MLA

Or, Chi-Hung R., et al. “Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells.” International Journal of Molecular Sciences, vol. 18, no. 1, Dec. 2016. EBSCOhost, https://doi.org/10.3390/ijms18010044.

APA

Or, C.-H. R., Chang, Y., Lin, W.-C., Lee, W.-C., Su, H.-L., Cheung, M.-W., Huang, C.-P., Ho, C., & Chang, C.-C. (2016). Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells. International Journal of Molecular Sciences, 18(1). https://doi.org/10.3390/ijms18010044

Chicago

Or, Chi-Hung R, Yachu Chang, Wei-Cheng Lin, Wee-Chyan Lee, Hong-Lin Su, Muk-Wing Cheung, Chang-Po Huang, Cheesang Ho, and Chia-Che Chang. 2016. “Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells.” International Journal of Molecular Sciences 18 (1). doi:10.3390/ijms18010044.